111 Inc (YI)
1.04
+0.01
(+0.97%)
USD |
NASDAQ |
Jun 25, 16:00
111 EPS Diluted (Annual): -0.6588 for Dec. 31, 2023
EPS Diluted (Annual) Chart
Historical EPS Diluted (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.6588 |
| December 31, 2022 | -0.7444 |
| December 31, 2021 | -1.251 |
| December 31, 2020 | -0.8028 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.8831 |
| December 31, 2018 | -1.156 |
| December 31, 2017 | -0.4564 |
| December 31, 2016 | -0.7776 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Annual) Range, Past 5 Years
-1.251
Minimum
2021
-0.6588
Maximum
2023
-0.8681
Average
-0.8028
Median
2020
EPS Diluted (Annual) Benchmarks
| Concord Medical Services Holdings Ltd | -0.9627 |
| Sinovac Biotech Ltd | -1.06 |
| CASI Pharmaceuticals Inc | -2.02 |
| Zai Lab Ltd | -3.50 |
| Adagene Inc | -0.4375 |